Taro Pharmaceutical Industries Ltd (NYSE:TARO)
| 37.15 BATS BZX Real-Time Price As of 1:06pm ET |  -0.17 / -0.46%Today’s Change | 22.89 Today|||52-Week Range 42.22 | +27.93% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Revenue and Income | Net Revenues | 154.6M | 159.0M | 176.4M | 179.9M | |
| Cost of Goods Sold | 50.2M | 45.9M | 53.9M | 55.5M | ||
| Depreciation And Amortization | 4.3M | 4.5M | 4.9M | 4.9M | ||
| Operating Expenses | Gross Income | 100.1M | 108.6M | 117.5M | 119.5M | |
| General Expenses | 36.9M | 33.8M | 38.6M | 43.8M | ||
| Research And Development | 13.3M | 14.7M | 14.7M | 20.5M | ||
| Total Operating Expenses | 91.5M | 84.3M | 97.4M | 104.2M | ||
| Non-Operating Expenses | Operating Income | 63.2M | 74.7M | 78.9M | 75.7M | |
| Extraordinary Credit | 0.00 | 4.0M | 0.00 | -- | ||
| Extraordinary Charge | 0.00 | 0.00 | 0.00 | -322.0K | ||
| Other Expenses | 10.6M | -6.0M | 32.1M | -9.8M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 81.5M | 81.8M | 119.4M | 74.1M | |
| Income Taxes | -14.1M | -19.2M | -25.8M | -15.6M | ||
| Minority Interest | -151.0K | -12.0K | -164.0K | -42.0K | ||
| Net Income | 67.3M | 62.6M | 93.5M | 58.4M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 39.4M | 39.4M | 38.9M | 38.5M | |
| Shares To Calculate EPS Diluted | 39.4M | 39.4M | 38.9M | 38.5M | ||
| Earnings Per Share | EPS | $1.71 | $1.59 | $2.40 | $1.52 | |
| EPS Diluted | $1.71 | $1.59 | $2.40 | $1.52 | ||
